Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Dextromethorphan inhibits activations and functions in dendritic cells.

Chen DY, Song PS, Hong JS, Chu CL, Pan IH, Chen YM, Lin CH, Lin SH, Lin CC.

Clin Dev Immunol. 2013;2013:125643. doi: 10.1155/2013/125643. Epub 2013 May 28.

2.

Antihelminthic niclosamide modulates dendritic cells activation and function.

Wu CS, Li YR, Chen JJ, Chen YC, Chu CL, Pan IH, Wu YS, Lin CC.

Cell Immunol. 2014 Mar-Apr;288(1-2):15-23. doi: 10.1016/j.cellimm.2013.12.006. Epub 2013 Dec 28.

PMID:
24561310
3.

IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.

Strengell M, Lehtonen A, Matikainen S, Julkunen I.

J Leukoc Biol. 2006 Jun;79(6):1279-85. Epub 2006 Mar 21.

PMID:
16551679
4.

Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.

Li L, Yang J, Jiang Y, Tu J, Schust DJ.

Mol Hum Reprod. 2015 Apr;21(4):369-81. doi: 10.1093/molehr/gav001. Epub 2015 Jan 14.

PMID:
25589517
5.

Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.

Xu MQ, Suo YP, Gong JP, Zhang MM, Yan LN.

World J Gastroenterol. 2004 Aug 15;10(16):2361-8.

6.

Impact of valproic acid on dendritic cells function.

Frikeche J, Simon T, Brissot E, Grégoire M, Gaugler B, Mohty M.

Immunobiology. 2012 Jul;217(7):704-10. doi: 10.1016/j.imbio.2011.11.010. Epub 2011 Dec 8.

PMID:
22209114
7.

Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naïve T cells into Th1 cells by increased IL-12 secretions.

Jeong YJ, Hong SW, Kim JH, Jin DH, Kang JS, Lee WJ, Hwang YI.

Cell Immunol. 2011;266(2):192-9. doi: 10.1016/j.cellimm.2010.10.005. Epub 2010 Oct 20.

PMID:
21074755
8.

Antithetical effects of hemicellulase-treated Agaricus blazei on the maturation of murine bone-marrow-derived dendritic cells.

Kawamura M, Kasai H, He L, Deng X, Yamashita A, Terunuma H, Horiuchi I, Tanabe F, Ito M.

Immunology. 2005 Mar;114(3):397-409.

9.

Synergy between vitamin D(3) and Toll-like receptor agonists regulates human dendritic cell response during maturation.

Brosbøl-Ravnborg A, Bundgaard B, Höllsberg P.

Clin Dev Immunol. 2013;2013:807971. doi: 10.1155/2013/807971. Epub 2013 Apr 7.

10.

Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β.

Motta JM, Sperandio A, Castelo-Branco MT, Rumjanek VM.

Hum Immunol. 2014 Jul;75(7):641-9. doi: 10.1016/j.humimm.2014.04.013. Epub 2014 Apr 24.

PMID:
24768898
11.

Immunomodulatory effect of protease hydrolysates from ovotransferrin.

Liu L, Xu M, Tu Y, Du H, Zhou Y, Zhu G.

Food Funct. 2017 Apr 19;8(4):1452-1459. doi: 10.1039/c6fo01669c.

PMID:
28275769
13.

D-pinitol inhibits Th1 polarization via the suppression of dendritic cells.

Lee JS, Jung ID, Jeong YI, Lee CM, Shin YK, Lee SY, Suh DS, Yoon MS, Lee KS, Choi YH, Chung HY, Park YM.

Int Immunopharmacol. 2007 Jun;7(6):791-804. Epub 2007 Feb 22.

PMID:
17466913
14.

Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharide-stimulated collagen-loaded dendritic cells.

Peña C, Gárate D, Contreras-Levicoy J, Aravena O, Catalán D, Aguillón JC.

Clin Dev Immunol. 2013;2013:296031. doi: 10.1155/2013/296031. Epub 2013 May 29.

15.

Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.

Zou W, Borvak J, Marches F, Wei S, Galanaud P, Emilie D, Curiel TJ.

J Immunol. 2000 Oct 15;165(8):4388-96.

16.

Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells.

Montesinos MM, Alamino VA, Mascanfroni ID, Susperreguy S, Gigena N, Masini-Repiso AM, Rabinovich GA, Pellizas CG.

Steroids. 2012 Jan;77(1-2):67-76. doi: 10.1016/j.steroids.2011.10.006. Epub 2011 Oct 25.

PMID:
22056479
17.

Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.

Kuroki H, Morisaki T, Matsumoto K, Onishi H, Baba E, Tanaka M, Katano M.

Cancer Immunol Immunother. 2003 Sep;52(9):561-8.

PMID:
14627128
18.

TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production.

Vogel SZ, Schlickeiser S, Jürchott K, Akyuez L, Schumann J, Appelt C, Vogt K, Schröder M, Vaeth M, Berberich-Siebelt F, Lutz MB, Grütz G, Sawitzki B.

J Immunol. 2015 Apr 1;194(7):3136-46. doi: 10.4049/jimmunol.1400713. Epub 2015 Mar 6.

19.

Immunosuppressive effect of quercetin on dendritic cell activation and function.

Huang RY, Yu YL, Cheng WC, OuYang CN, Fu E, Chu CL.

J Immunol. 2010 Jun 15;184(12):6815-21. doi: 10.4049/jimmunol.0903991. Epub 2010 May 17.

20.

Apicidin, the histone deacetylase inhibitor, suppresses Th1 polarization of murine bone marrow-derived dendritic cells.

Jung ID, Lee JS, Jeong YI, Lee CM, Chang JH, Jeong SK, Chun SH, Park WS, Han J, Shin YK, Park YM.

Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):501-15.

PMID:
19505402

Supplemental Content

Support Center